Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Surgery Partners, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Surgery Partners, Inc. (SGRY) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Surgery Partners, Inc. (“Surgery Partners”) (NASDAQ: SGRY) and HealthSpan Partners (“HealthSpan”). Investors who purchased Surgery Partners and continue to hold to the present are encouraged to obtain additional information and assist the investigation.
The Company announced on October 26, 2026, that it has agreed to be acquired by HealthSpan for $23.50 per share.
What Potential Securities Violations Is BG&G Investigating?
- Whether Surgery Partners, Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Surgery Partners, Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Surgery Partners, Inc. (SGRY) Investors Do?
How Is Surgery Partners, Inc. (NASDAQ: SGRY) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”